DermTech (DMTKQ)
(Delayed Data from OTC)
$0.07 USD
+0.01 (10.45%)
Updated Jul 17, 2024 01:48 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
DMTKQ 0.07 +0.01(10.45%)
Will DMTKQ be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DMTKQ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for DMTKQ
DermTech Files for Voluntary Chapter 11 Protection
DermTech Reports First-Quarter 2024 Financial Results
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan